Literature DB >> 1648991

[Demonstration of an engagement process towards cell death by apoptosis in lymphocytes of HIV infected patients].

M L Gougeon1, R Olivier, S Garcia, D Guetard, T Dragic, C Dauguet, L Montagnier.   

Abstract

Peripheral blood lymphocytes from AIDS patients or from infected asymptomatic individuals display a rapid loss of viability upon culture in a survival medium. Cellular death occurs following endonucleosomal DNA fragmentation (apoptosis), which is preceeded by chromatin condensation and lower staining with orange acridine. This phenomenon is accelerated by compounds known to activate lymphocytes (such as ionophores) and is partly or entirely suppressed by addition of a cytokine crude preparation, enriched in IL2. All together, these results suggest that in vivo a significant fraction of patients' lymphocytes is engaged towards a preapoptosis process resulting from abnormal activation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1648991

Source DB:  PubMed          Journal:  C R Acad Sci III        ISSN: 0764-4469


  13 in total

1.  Induction of CD95 ligand expression on T lymphocytes and B lymphocytes and its contribution to apoptosis of CD95-up-regulated CD4+ T lymphocytes in macaques by infection with a pathogenic simian/human immunodeficiency virus.

Authors:  Y Sasaki; Y Ami; T Nakasone; K Shinohara; E Takahashi; S Ando; K Someya; Y Suzaki; M Honda
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

2.  Improvement of the lymphoproliferative immune response and apoptosis inhibition upon in vitro treatment with zinc of peripheral blood mononuclear cells (PBMC) from HIV+ individuals.

Authors:  I Neves; A L Bertho; V G Veloso; D V Nascimento; D L Campos-Mello; M G Morgado
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

3.  Detection and quantification of live, apoptotic, and necrotic human peripheral lymphocytes by single-laser flow cytometry.

Authors:  T J Liegler; W Hyun; T S Yen; D P Stites
Journal:  Clin Diagn Lab Immunol       Date:  1995-05

4.  Programmed cell death in brains of HIV-1-positive AIDS and pre-AIDS patients.

Authors:  S F An; B Giometto; T Scaravilli; B Tavolato; F Gray; F Scaravilli
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

5.  Induction of "tissue" transglutaminase in HIV pathogenesis: evidence for high rate of apoptosis of CD4+ T lymphocytes and accessory cells in lymphoid tissues.

Authors:  A Amendola; M L Gougeon; F Poccia; A Bondurand; L Fesus; M Piacentini
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

6.  Malaria associated apoptosis is not significantly correlated with either parasitemia or the number of previous malaria attacks.

Authors:  Evelyn K P Riccio; Ivan Neves Júnior; Lilian R Pratt Riccio; Maria das Graças Alecrim; Suzana Corte-Real; Mariza Morgado; Cláudio T Daniel-Ribeiro; Maria de Fátima Ferreira-da-Cruz
Journal:  Parasitol Res       Date:  2003-01-28       Impact factor: 2.289

7.  Two subpopulations of human triple-negative thymic cells are susceptible to infection by human immunodeficiency virus type 1 in vitro.

Authors:  H Valentin; M T Nugeyre; F Vuillier; L Boumsell; M Schmid; F Barré-Sinoussi; R A Pereira
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

8.  Analysis of lymphocyte cell death and apoptosis in HIV-2-infected patients.

Authors:  A C Jaleco; M J Covas; R M Victorino
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

9.  Genomic analysis of Fas and FasL genes and absence of correlation with disease progression in AIDS.

Authors:  A Vasilescu; S C Heath; G Diop; H Do; T Hirtzig; H Hendel; S Bertin-Maghit; J Rappaport; A Therwath; G M Lathrop; F Matsuda; J-F Zagury
Journal:  Immunogenetics       Date:  2004-03-23       Impact factor: 2.846

10.  Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals.

Authors:  H Groux; G Torpier; D Monté; Y Mouton; A Capron; J C Ameisen
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.